Bio-Rad Laboratories, Inc.Class A BIO
$361.19
-0.25%
at last close
Analyst Consensus
- Consensus Rating
- Hold (1 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $350.00
- Implied Upside
- -3.1%
- Price Target Range
- $330.00 – $390.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | RBC CapitalDan Leonard |
Maintains | Outperform | $370 → $390 |
| 2026-08-05 | CitigroupDaniel Grosslight |
Maintains | Neutral | $300 → $330 |
| 2026-08-05 | RBC CapitalDan Leonard |
Maintains | Outperform | $320 → $370 |
| 2026-08-05 | Wells FargoEvan Stampler |
Maintains | Equal-weight | $310 → $330 |
| 2026-05-15 | RBC CapitalDan Leonard |
Reinstates | Outperform | $320 |
| 2026-05-01 | Wells FargoBrandon Couillard |
Maintains | Equal-weight | $320 → $290 |
| 2026-04-07 | CitigroupPatrick Donnelly |
Downgrades | Buy → Neutral | $375 → $300 |
| 2025-10-30 | CitigroupPatrick Donnelly |
Maintains | Buy | $350 → $375 |
| 2025-10-30 | Wells FargoBrandon Couillard |
Maintains | Equal-weight | $265 → $340 |
| 2025-08-01 | RBC CapitalConor McNamara |
Maintains | Outperform | $387 → $409 |
| 2025-08-01 | Wells FargoBrandon Couillard |
Maintains | Equal-weight | $245 → $265 |
| 2025-06-09 | Wells FargoBrandon Couillard |
Maintains | Equal-weight | $260 → $245 |
| 2025-05-02 | UBSDan Leonard |
Maintains | Buy | $355 → $310 |
| 2025-05-02 | CitigroupPatrick Donnelly |
Maintains | Buy | $400 → $350 |
| 2025-05-02 | RBC CapitalConor McNamara |
Maintains | Outperform | $409 → $392 |
| 2025-04-17 | Wells FargoBrandon Couillard |
Maintains | Equal-weight | $320 → $270 |
| 2025-02-12 | Wells FargoBrandon Couillard |
Maintains | Equal-weight | $360 → $345 |
| 2025-01-14 | RBC CapitalConor McNamara |
Reiterates | Outperform | $481 |
| 2024-12-09 | RBC CapitalConor McNamara |
Maintains | Outperform | $369 → $481 |
| 2024-10-31 | CitigroupPatrick Donnelly |
Maintains | Buy | $400 → $450 |
| 2024-10-31 | RBC CapitalConor McNamara |
Maintains | Outperform | $446 → $469 |
| 2024-10-01 | CitigroupPatrick Donnelly |
Upgrades | Neutral → Buy | $350 → $400 |
| 2024-08-27 | Wells FargoBrandon Couillard |
Initiates coverage on | Equal-weight | $340 |
| 2024-08-16 | RBC CapitalConor McNamara |
Reiterates | Outperform | $401 |
| 2024-08-02 | RBC CapitalConor McNamara |
Maintains | Outperform | $402 → $401 |
| 2024-08-02 | CitigroupPatrick Donnelly |
Maintains | Neutral | $300 → $350 |
| 2024-06-03 | Jefferies |
Assumes | Buy → Hold | $440 → $315 |
| 2024-05-08 | UBSDan Leonard |
Maintains | Buy | $420 → $385 |
| 2024-04-03 | CitigroupPatrick Donnelly |
Downgrades | Buy → Neutral | $400 → $365 |
| 2024-02-16 | UBSDan Leonard |
Maintains | Buy | $395 → $420 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $361.19
- Market Cap
- $9.68 billion
- 52-Week Range
- $236.73 – $365.00
- Average Volume
- 298K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.